SBL
QTTB icon

Sargent Bickham Lagudis’s Q32 Bio QTTB Stock Holding History

Sargent Bickham Lagudis’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$252 Buy
+11
New +$292 ﹤0.01% 1013
2021
Q2 		– Sell
-6
Closed -$1K – 1012
2021
Q1 		$1K Hold
6
– – ﹤0.01% 912
2020
Q4 		$1K Buy
+6
New +$1.16K ﹤0.01% 854

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Sargent Bickham Lagudis's QTTB Position: Q4 2022 in Review

Sargent Bickham Lagudis opened a new position in Q32 Bio (QTTB) in Q4 2022: 11 shares worth $252. The stake represents ﹤0.01% of the portfolio and ranks #1013 among its holdings. This is a return to the name: Sargent Bickham Lagudis previously reported a position in QTTB as recently as Q1 2021.

Sargent Bickham Lagudis first reported a position in QTTB in Q4 2020 and has held it in 3 quarters since. The position peaked at $1K in Q1 2021. 79 funds tracked by Wall St. Rank hold QTTB as of Q4 2022.

  • Sargent Bickham Lagudis held 11 shares of Q32 Bio worth $252 as of Q4 2022.
  • Q32 Bio was a new Sargent Bickham Lagudis position in Q4 2022.
  • Q32 Bio made up ﹤0.01% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #1013 holding.
  • Sargent Bickham Lagudis first reported a position in Q32 Bio in Q4 2020 and has held it in 3 quarters since.
  • Sargent Bickham Lagudis's Q32 Bio position peaked at $1K in Q1 2021.
  • 79 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.